Ronipamil is a calcium ion antagonist. Ronipamil increases the specific binding and internalization of human 125I-LDL in human skin fibroblasts (HSF) and the human hepatoma cell line Hep G2[1].
References
[1] Corsini A, et al. Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2[J]. Pharmacological research communications, 1986, 18(1): 1-16. DOI:10.1016/0031-6989(86)90155-4
